EU SCENIHR yet to adopt second opinion on safety of PIP breast implants
This article was originally published in Clinica
Executive Summary
Further delays have stalled EU regulators from adopting the second opinion, issued by the European Commission’s scientific committee that assesses emerging and newly identified health risks (SCENIHR), on the safety of PIP silicone breast implants.